SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 111 filers reported holding SCHOLAR ROCK HLDG CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,612 | -57.3% | 55,720 | -51.9% | 0.00% | – |
| Q1 2023 | $927,472 | -13.0% | 115,934 | -1.6% | 0.00% | – |
| Q4 2022 | $1,066,660 | -49.2% | 117,863 | -61.1% | 0.00% | – |
| Q3 2022 | $2,101,000 | +34.7% | 303,126 | +6.7% | 0.00% | – |
| Q2 2022 | $1,560,000 | -60.6% | 284,167 | -7.6% | 0.00% | -100.0% |
| Q1 2022 | $3,962,000 | +47.1% | 307,413 | +276.9% | 0.00% | 0.0% |
| Q3 2021 | $2,693,000 | -38.1% | 81,570 | -45.8% | 0.00% | 0.0% |
| Q2 2021 | $4,352,000 | +50.0% | 150,581 | +162.9% | 0.00% | 0.0% |
| Q1 2021 | $2,902,000 | -56.5% | 57,275 | -58.3% | 0.00% | -50.0% |
| Q4 2020 | $6,671,000 | +351.0% | 137,466 | +64.4% | 0.00% | – |
| Q3 2020 | $1,479,000 | +75.7% | 83,607 | +80.7% | 0.00% | – |
| Q2 2020 | $842,000 | +338.5% | 46,269 | +192.1% | 0.00% | – |
| Q1 2020 | $192,000 | -57.9% | 15,839 | -54.2% | 0.00% | – |
| Q4 2019 | $456,000 | +54.6% | 34,608 | +5.0% | 0.00% | – |
| Q3 2019 | $295,000 | -22.4% | 32,945 | +37.6% | 0.00% | – |
| Q2 2019 | $380,000 | – | 23,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |